FDA Law Weekly

Celje General Hospital - Etidronate fails to prevent periprosthetic bone loss after cemented hip arthroplasty

Celsion Corp. - Cancer treatment subsidiary sold to former CEO Augustine Cheung

Celsion Corp. - Dr. William Hahne and Dr. Christopher Black join biotech company

Center Antoine Lacassagne, Nice - Role of imaging in evaluating metastatic disease from breast cancer reviewed

Center for Addiction & Mental Health, Toronto - Olanzapine reported to be associated with significantly greater weight gain than haloperidol

Chaoyang University of Technology, Wufeng - Novel flavonoid derivatives evaluated for anticancer activity

Chiba University Hospital - Surgery and T stage prognosticated outcome of SCC of the maxillary sinus

Children's National Medical Center, Washington, DC - Transdermal fentanyl system provides safe relief of chronic severe pain

Chinese Academy of Medical Science, Beijing - Foscarnet reduces hepatitis B virus DNA replication

Chungnam National University, Taejon - IL-12 and TNF-alpha differentially regulated by PI 3-K and ERK 1/2 pathways in MTB infection

City Hospital, Nottingham - Study of cytokines in neuropathic osteoarthropathy may lead to novel treatment option

Cleveland Clinic Foundation - Laparoscopic partial nephrectomy suitable for small tumor treatment

Cleveland Clinic Foundation - Review examines HDL-raising strategies in treatment of coronary artery disease

CoLucid Pharmaceuticals, Inc. - Indiana fund invests in pharma firm developing migraine drug

Cobalis Corp. - PreHistin approval process to be conducted by OTC division of U.S. FDA

Colon Cancer - Pleural effusion following hepatic radiofrequency used to treat hepatic tumors

Columbia University, New York - Studies advance knowledge in proteomics research

Dana-Farber Cancer Institute - Molecular interaction found to trigger particularly aggressive form of disease

Delaware County Memorial Hospital, Drexel Hill - Fluorouracil plus radiotherapy did not improve cervix cancer over cisplatin

Dermatology - Osteoporosis risk not being addressed in patients on glucocorticoid therapy

Disease Associations - Withdrawal of bisphosphonates not recommended for necrosis of the jaws

Drug Abuse - Methamphetamine-related treatment admissions continue to rise in Minnesota cities

Duke University, Durham - Researchers publish new studies and findings in the area of mental health

Eli Lilly & Co. - Immediate switching from an SSRI or venlafaxine to duloxetine is well tolerated

Gambro Dasco, SpA - U.S. FDA issues warning letter to Italian monitor manufacturing facility

Hollis-Eden Pharmaceuticals, Inc. - Pharma firm to develop therapy for acute radiation syndrome

Medarex, Inc. - PharmAthene and biopharma company receive $2.05 million for development of Valortim

Medical Carbon Research Institute - U.S. FDA approves investigational clinical trial of On-X Prosthetic Heart Valve

Molecular Devices Corporation - Bioanalytical measurement systems company introduces new software for microplate readers

Rockwell Medical Technologies, Inc. - Dialysis products manufacturer completes phase III trial of hemodialysis iron-delivery product

Saint Louis University School of Medicine - Bird flu infections in humans prompt new vaccine studies

Starpharma - IND for prevention of HIV receives fast tracks status from U.S. FDA

Swiss Tropical Institute, Basel - W135 meningococcal meningitis rapidly evolving in Ghana

U.S. Centers for Disease Control & Prevention - Report describes adverse events linked to smallpox vaccine in U.S.

U.S. Food & Drug Administration - Adverse events are more likely when influenza vaccine is used inconsistent with labeling

U.S. Food & Drug Administration - Study examined response of lipid bilayers and monolayers to trehalose

University of Minnesota - Invasive pneumococcal disease is declining in U.S. elderly